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Abstract  
 
Traditional medicinal plants have been the origin and basis of pharmacology and therapeutics. On the other side, over the last decades, natural product and 
medicinal plant research have been cut down within pharmaceutical companies claiming economic and availability reasons. However, traditional medicinal 
plants have played an important role in drug discovery. For these reason, ethnobotany and traditional medicine may still be a useful strategy and a valuable 
tool for future pharmaceutical research. 
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Resumen 
 
Las plantas medicinales tradicionales han constituido el origen y las bases de la farmacología y la terapéutica. Por otro lado, en las últimas décadas, la 
investigación sobre productos naturales y plantas medicinales se ha reducido considerablemente en las industrias farmacéuticas debido a diversos motivos, 
entre ellos disponibilidad y coste. Sin embargo, las plantas medicinales con usos tradicionales han jugado un papel fundamental y decisivo en el 
descubrimiento de nuevos fármacos. Por este motivo, la etnobotánica y la medicina tradicional todavía pueden constituir una estrategia útil y una herramienta 
valiosa para la investigación farmacéutica del futuro. 
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INTRODUCTION 
Nature is a source of biologically active 
compounds and natural products have been used as 
medicines throughout the history of mankind. 
Although natural products include plant, animal and 
microbial sources, plants have been the origin and 
basis of pharmacy and pharmacology, constituting 
remedies in traditional medical systems and still being 
used as a source of bioactive compounds. An example 
of this fact may be morphine from poppy (Papaver 
somniferum L., Papaveraceae). Dioscorides (70 AD) 
described Papaver somniferum regarding analgesic 
effects. Currently, it is cultivated to extract poppy 
juice from which the opioid analgesic morphine is 
purified to be part of painkiller formulations in 
chemotherapeutic patients (Samuelsson, 2004). 
Natural products have been the active 
ingredient of medicines for years but they may still be 
the leads for new drugs (Newman, 2008). Since the 
1980s, the influence of natural products in drug 
discovery has been significant. Between 1981 and 
2006, more than 50 % of approved drugs were based 
on natural product structures: 5.7 % natural products, 
27.6 % derived from a natural product often by semi-
synthesis, 17.1 % made by total synthesis but the 
pharmacophore was from a natural product (Newman 
& Cragg, 2007). In 2001-2002 approximately 25 % of 
the best-selling drugs worldwide were natural products 
or derivatives (Butler, 2004). It is also worth 
mentioning some new plant-derived drugs introduced 
in the pharmaceutical market in the last years (fig. 1)  
(Balunas & Kinghorn, 2005). Arteeter (Artemotil
®
) is 
an antimalarial drug derived from the natural 
compound artemisinin; artemisinin is a sesquiterpene 
lactone isolated from Artemisia annua L. (Asteraceae), 
a medicinal plant used in traditional Chinese medicine 
(TCM) to threat malaria. Galantamine (Reminyl
®
), 
isolated from different species of Amaryllidaceae, is 
approved for Alzheimer´s disease. Nitisinone 
(Orfadin
®
), based on leptospermone from Callistemon 
citrinus Stapf. (Myrtaceae), is an orphan drug for the 
trealment of tyrosinaemia. Tiotropium (Spiriva
®
), 
based on atropine from Atropa belladonna L. 
(Solanaceae) to treat patients with chronic obstructive 
pulmonary disease. Nabilone (Cesamet
®
), approved in 
2006 for the treatment of nausea and vomiting in 
chemotherapy, is a synthetic derivative of 
9
-
tetrahydrocannabinol (THC) from Cannabis sativa L. 
(Cannabaceae) (Saklani & Kutty, 2008). However, 
natural products obtained from other sources are 
succeeding; for example, Trabectedin (Yondelis
®
), 
isolated from the marine tunicade Ecteinascidia 
turbinate, was approved in 2007 by EMEA for the 
treatment of soft tissue sarcoma after failure to 
standard chemotherapy (Nobili et al., 2009). Among 
them, arteeter, galantamine, tiotropium and nabilone 
may be considered as developed based on previous 
traditional uses of the plants. 
 
 
 
Figure 1.Plant-derived drugs recently developed based 
on traditional uses of the plant source 
 
In 2008, over 100 natural product-based on 
compounds were under clinical investigations at 
different stages (Harvey, 2008). Almost the same 
amount is in preclinical research which means that 
natural product have been a great source of leads for 
drug discovery. Most of them are plant-derived drugs, 
followed by semi-synthetics, microbials and from 
animal origin, the main therapeutic categories being 
anticancer, anti-infective and neurological drugs 
(Harvey, 2008). Calanolide A, a coumarin isolated 
from Calophyllum lanigerum var. austrocoriaceum 
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(Whitmore) P.F. Stevens (Clusiaceae) by the National 
Cancer Institute, is currently in clinical trials for its 
anti-HIV and anti-tuberculosis activities (Kashman et 
al., 1992); other calanolides are also under pre-clinical 
stage. ZT-1 is a pro-drug of huperzine isolated from 
Huperzia serrata (Thunb. ex Murray) Trev. 
(Lycopodiaceae) that is also undergoing trials for the 
trealment of Alzheimer´s disease due to working as N-
methyl-aspartate receptor antagonist and 
acetylcholinesterase inhibitor. Dexabinol is a 
neuroprotective non-psychotropic cannabinoid 
undergoing Phase III trials for brain injury. Many 
plant-based products are in clinical development as 
anticancer drugs: daidzein, an isoflavone from 
soybean, protopanaxadiol, a tetracyclic triterpene from 
ginseng, and kahalalide F, a peptide toxin from the 
mollusc Elysia rubefescens (Saklani & Kutty, 2008). 
Apart from being a source of compounds, 
medicinal plants constitute by themselves herbal 
remedies used in rational phytotherapy and/or 
complementary medicine. Concerning traditional 
herbal remedies, some examples may be remarked due 
to its high use worldwide. The roots and rhizomes of 
valerian (Valeriana officinalis L., Valerianaceae) are 
worldwide appreciated as a mild sedative (Bent et al., 
2006). Other herbal remedies working on CNS are St. 
John’s Wort (Hypericum perforatum L., Clusiaceae) 
with antidepressant clinical efficacy (Kasper et al., 
2008) and roots of Panax ginseng C.A. Meyer 
(Araliaceae) considered as an adaptogenic that 
increases inespecific resistence of organism (Naval et 
al., 2007; Wu et al., 2009). Aloe preparations, made 
with the parenchyma of different species of the genus 
Aloe, are very popular for skin affections (Feily & 
Namazi, 2009) and herbal teas such as chamomile or 
pennyroyal as digestives (Kato et al., 2008).  
It seems obvious that medicinal plants are a 
source for pharmacologically active products in 
developed countries but they have also been the basis 
of different traditional medical systems in developing 
areas. According to WHO, most of the world’s 
population still relies on plants for their healthcare. In 
some Asian and African countries, 80% of the 
population depends on traditional medicinal plants for 
primary healthcare, as they are either the most 
accessible or the only available treatment (Gurib-
Fakim, 2006). 
It is estimated that the number of higher plant 
species on the planet may be over 250,000 and only 
10% have yet been biologically studied (Harvey, 
2000). In this sense, the potential for finding new 
medicinal plants and new lead compounds for new 
generations of drugs is enormous. 
 
Advantages versus disadvantages in medicinal 
plant research 
Exploring natural resources for drug discovery 
and development may represent advantages compared 
to some other approaches (Lam, 2007). Natural 
products offer chemical diversity, structural 
complexity and a range of biological activities that is 
not comparable to synthetic approaches. Natural 
compounds can be used as templates to obtain new 
chemical entities of pharmaceutical interest. Drugs 
from natural origin have helped to discover human 
physiological pathways. For example, cannabinoids 
from Cannabis sativa (the hemp plant) led to the 
elucidation of the endogen cannabinoid system or 
salicylic acid from Salix alba (white willow bark) led 
to the discovery of COX enzymes related to 
inflammation (Bosch  Banos, 1998). Digoxin from 
foxglove (Digitalis purpurea L., Scrophulariaceae) 
led to the discovery of the sodium-potassium ATP-ase 
pump biochemistry and enabled a better understanding 
of cardiac pathologies (Rishton, 2008). Muscimol 
from Amanita muscaria (fly agaric mushroom) has 
been crucial in differentiating the pharmacology of 
GABAA and GABAB receptor subtypes related to a 
range of central nervous system disorders. Due to the 
fact that natural products have been produced by a 
living organism, they frequently exert adequate 
pharmacokinetic properties in terms of absorption, 
distribution, and metabolism, as happened with 
streptomycin, amphotericin B, cyclosporine A or 
lovastatin, marketed without modifications. 
Traditional herbal remedies have been selected by 
mankind through trial-and-error for centuries, which 
may give clues about interesting biological properties 
(Gurib-Fakim, 2006). Several plant-derived drugs 
have been developed on the basis of ethnomedical-
ethnobotanical information as for instance galantamine 
isolated from the genus Galanthus and relatives of the 
Amaryllis family registered for the treatment of 
Alzheimer´s disease under the name Reminyl® 
(Heinrich & Lee, 2004). 
Despite the success of natural products in drug 
discovery and therapeutics, pharmaceutical companies 
have decreased their efforts in natural products and 
medicinal plant research due to some disadvantages 
and difficulties mentioned below (Fabricant & 
Farnsworth, 2001; Lam, 2007). Biological systems 
(plant, animal, microbial) have a potential variability 
that results in differences in terms of composition and 
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therefore biological activity. Collection of plants and 
other samples may be difficult and conditioned by 
abundance and accessibility; for instance, collection of 
marine organisms requires qualified people and 
expensive facilities. The issue of intellectual property 
rights; the Convention on Biological Diversity (CBD) 
drew up its objectives in 1992 in Rio de Janeiro 
(Gurib-Fakim, 2006): “…the conservation of 
biological diversity, the sustainable use of its 
components and the fair and equitable sharing of the 
benefits arising out of the utilization of genetic 
resources, including by appropriate access to genetic 
resources and by appropriate transfer of appropriate 
technologies, taking into account all rights over those 
resources and to technologies, and by appropriate 
funding”. Natural products are synthesized and 
presented in small quantities in complex-mixtures 
involving an intensive purification and isolation 
process. Natural products are sometimes complex 
structures, being a challenge for combinatorial 
chemistry. 
All these facts mentioned above are not within 
the scope of pharmaceutical firms in which time-cost 
is a limiting factor. The drug discovery process is 
estimated to take 10 years and cost 800 million dollars 
(Dickson & Gagnon, 2004). For every 5000 lead 
compounds only one would reach the approval for 
marketing. Drug discovery from medicinal plants is 
generally longer and more expensive than other 
strategies. Owing to this, the current main strategies 
for drug discovery are combinatorial chemistry and 
high-throughput screening (HTS) techniques.  
 
Traditional medicine (TM), ethnobotany and 
ethnopharmacology 
Throughout history, different cultures have 
developed knowledge about herbal remedies that has 
been passed from generation to generation constituting 
what is called traditional medicine (Gurib-Fakim, 
2006). But the concept of traditional medicine is 
wider. According to WHO, TM is defined as diverse 
health practices, approaches, knowledge and beliefs 
incorporating plant, animal and/or mineral based 
medicines, spiritual therapies, manual techniques and 
exercises applied singularly or in combination to 
maintain well-being, as well as to threat, diagnose or 
prevent illness (WHO, 2002). 
Taking into account that practically 80% of 
the world’s population lives in developing countries 
and about 80% of these people use TM systems, it is 
obvious that most of the world’s population still 
depend on traditional remedies for their primary 
healthcare. This wide use in the developing areas such 
as Africa, Asia and Latin America is due to 
affordability and accessibility of the natural sources. 
On the contrary, developed countries are increasing 
their use of traditional medicinal plants in forms of 
rational phytotherapy, dietetics and complementary  or 
alternative medicine (WHO, 2002) 
The term ethnomedicine or TM is sometimes 
used as synonym of ethnobotany and 
ethnopharmacology to express the same idea although 
there are substantial differences between them. 
Ethnobotany may be defined as the science of people’s 
interaction with plants (Turner, 1995). The objectives 
of ethnobotany include contribute to the knowledge of 
biodiversity (Bonet & Valles, 2002) and to the cultural 
meaning of plant sources (Bonet et al., 1999) and 
explore biodiversity for new sources of natural 
products with pharmaceutical interest (bioprospecting) 
(McClatchey et al., 2009). 
In addition, ethnopharmacology is a 
multidisciplinary area of research concerned with the 
observation, description and experimental 
investigation of indigenous drugs ad their biological 
activities (Rivier & Bruhn, 1979). While 
ethnopharmacology deals with drugs from animal, 
microbial or plant sources, ethnobotany is only 
focused on plants.  
These three concepts have a common area, 
which is the use of herbal remedies by the different 
cultures. It is difficult to understand them individually 
as in many cases ethnobotanical/ethopharma-
cological/ethnomedicinal studies have common 
objectives and may be valuable approaches for drug 
discovery. Farnsworth et al. (1985) identified up to 
122 compounds used in therapeutics that were from 
plant origin and nearly 80 % were used for the same or 
related disorder than in traditional medicine. Some 
examples of current drugs with an ethnomedicinal 
origin are described in Table 1. 
 
Traditional medicinal plants of importance in 
western medicine 
African medicine is considered to be the oldest 
(Gurib-Fakim, 2006) as the ancient African continent 
is the origin of mankind. It is considered a holistic 
system as it involves the body and the mind. African 
traditional medical practice may include medical 
elements as well as psychological, spiritual and 
cultural aspects (Stafford et al., 2008). These 
techniques are usually practiced by a traditional healer 
that is also a religious leader. Plants are used as a 
pharmacological tool but it is also a living organism 
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that generates a “vital force”. Well-known African 
medicinal plants are Harpagophytum procunbens 
(Burch.) DC. ex Meissner (Pedaliaceae) and Prunus 
africana (Hook. f.) Kalkman (Rosaceae), that are used 
in western countries as anti-inflammatory and for the 
treatment of benign prostatic hyperplasia, respectively. 
Aspalanthus linearis (Burm.f.) R. Dahlgr. (Fagaceae), 
known as rooibos tea, is consumed in developed 
countries as a relaxing herbal tea. Aloe ferox Miller 
(Asphodelaceae) is widely used externally for skin 
problems due to its calming and regenerative 
properties and internally for the treatment of 
constipation . Studies on Catharanthus roseus (L.) G. 
Don.f. (Apocynaceae) from Madagascar led to the 
isolation of vincristine and vinblastine as anticancer 
agents. Finally, a steroid glycoside from Hoodia 
gordonii (Masson) Sweet ex Decne (Apocynaceae), a 
traditional plant used by the people of Kalahari desert 
to avoid hunger, is undergoing Phase II clinical trials 
for the treatment of obesity (Saklani & Kutty, 2008).  
 
Table 1.Examples of plant-derived drugs developed on the basis of ethnobotanical information 
 
Drug Current use Lead compound Botanical source Ethnomedical 
information 
(Origin) 
Acetylsalicylic 
acid 
Anti-inflammatory 
Antiagregant 
Salicin Salix sp (Salicaceae) Inflammation 
(Europe,Asia, 
America) 
Arteeter Antimalarial Artemisinin Artemisia annua L. 
(Asteraceae) 
Antimalarial 
(China) 
Atropine Anticholinergic (-)Hyosciamine Atropa belladonna L. 
(Solanaceae) 
Pan relief, asthma, 
(Europe) 
Colchicine Antigout Colchicine Colchicum autumnale L. 
(Liliaceae) 
Poison 
(Europe) 
Chromoglycate Anti-inflammatory in 
asthma 
Kellin Ammi visnaga (L). Lam. 
(Apiaceae) 
Inflammatory 
conditions (North 
Africa) 
Galantamine Colinesterase inhibitor 
(Alzheimer) 
Galantamine Galanthus sp 
(Amaryllidaceae) 
Nerve pain (Eastern 
Europe) 
Digoxin Cardiotonic Digoxin Digitalis sp 
(Scrophulariaceae) 
Dropsy (Europe) 
Etoposide Antitumour Podophylotoxin Podophyllum peltatum 
(Berberidaceae) 
Laxative, skin 
infections (North 
America) 
Morphine Opioid analgesic Morphine Papaver somniferum L. 
(Papaveraceae) 
Pain relief (Western 
Mediterranean) 
Pseudoephedrine -adrenergic agonist (nasal 
decongestant) 
Ephedrine Ephedra sinica Stapf 
(Ephedraceae) 
Cough suppressant 
(China) 
Rivastigmine Cholinesterase inhibitor Physostigmine Physostigma venenosum 
Balf. (Fabaceaea) 
Poison (Africa) 
Vinblastine, 
Vincristine 
Vinorelbine 
Antitumour Vinblastine, 
Vincristine 
Catharanthus roseus (L.) 
G. Don. f. (Apocynaceae) 
Hypoglucemiant 
(Madagascar) 
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Traditional Chinese medicine (TCM) is 
another holistic medicine where balance and harmony 
are of great importance. This system is believed to be 
5000 years old and still remains as in primary health 
care (Heinrich et al., 2003). The five-elements theory 
explain that the earth is divided into wood, fire, earth, 
metal and water, each of which is associated with a 
vital organ (liver, heart, spleen, lungs, kidneys, 
respectively). The disease is understood as a result of 
external forces (wind, cold, heat…) and emotions (joy, 
anger, anxiety, fear…). The treatments are focused in 
restoring the harmony and medicinal plants are usually 
given in complex mixtures. Examples of Chinese 
plants that led to important drugs are Ephedra sinica 
Stapf (Ephedraceae), Artemisia annua L. 
(Asteraceae), and Ginkgo biloba L. (Ginkgoaceae), 
sources of ephedrine, artemisinin and ginkgolides, 
repectively. Other plants widely used in western 
phytotherapy are ginseng (Panax ginseng C.A. Meyer, 
Araliaceae), ginger (Zingiber officinalis Rosc., 
Zingiberaceae), salvia (Salvia miltiorrhiza Bunge, 
Lamiaceae) and soybean (Glycine spp, Fabaceae). 
Huperzine A isolated from Huperzia serrata (Thunb. 
ex Murray) Trev. (Lycopodiaceae) has attracted 
attention as a novel drug candidate for Alzheimer’s 
disease (Ma et al., 2007). 
Ayurveda (Indian traditional medicine) is 
another holistic system that means knowledge of life 
and is considered to be the oldest systematized 
traditional medicine (Gurib-Fakim, 2006). It has 
similarities with Chinese traditional medicine. For 
example, the five elements (space, air, fire, water and 
earth) that are manifested in the body as three humors. 
Illness is believed as an imbalance of the elements and 
treatments include herbal remedies, yogic breathing 
and other techniques. Research in ayurvedic plants led 
to interesting compounds such as alkaloids for 
hypertension from Rauwolfia serpentine Benth. ex 
Kurz (Apocynaceae), anti-inflammatory curcumin 
from Curcuma longa L. (Zingiberaceae) or 
guggulsterons from Commiphora mukul Engl. 
(Burseraceae) as hypolipidemic agents. Black pepper 
(Piper nigrum L., Piperaceae) is used in Ayurveda as 
a digestive remedy. In recent years, many studies have 
been carried out in Withania somnifera Dunal 
(Solanaceae), considered an Indian ginseng due to 
adaptogenic properties (Kulkarni & Dhir, 2008). This 
plant contains steroidal alkaloids and lactones that 
may be useful in neurodegenerative and 
neuropsyquiatric disorders. 
Latin American traditional medicine is still 
practised, especially in rural areas of Central and 
South America, by a traditional healer or shaman that 
combines medical knowledge with cultural and 
religious beliefs. The remedies are often kept secret by 
the healer and have not been properly recorded as in 
TCM or Ayurveda. Some important medicinal plants 
originating from Latin America are mentioned bellow: 
Myroxylon balsamum (L.) Harms (Fabaceae) used as 
antiseptic and expectorant, Peumus boldus M. 
(Monimiaceae) for gastrointestinal disorders, 
Pilocarpus jaborandi Holmes (Rutaceae) for the 
extraction of pilocarpine used in glaucoma patients, 
Passiflora incarnata L. (Passifloraceae) for sleep 
disorders, Cinchona pubescens Vahl (Rubiaceae) as an 
antimalarial drug, Uncaria tomentosa (Willd.) DC 
(Rubiaceae) as an anti-inflamatory remedy and 
Lepidium peruvianum Chacón (Brassicaceae) as an 
adaptogenic plant food. Other plants of cultural 
importance are Theobroma cacao L. (Sterculiaceae), 
Erytrolyxum coca Lam. (Erytroxylaceae), Paullinia 
cupana H.B.K. (Sapindaceae) known as “guaraná” 
and Ilex paraguariensis St. Hil. (Aquifoliaceae) as 
“mate”. 
 
CONCLUSSION 
Medicinal plant research has been cut down in 
many companies as it involves some disadvantages 
such as chemical complexity and/or availability but 
the main being that is very cost intensive. Because of 
these arguments, the current trends for drug discovery 
in the biomedical industry are combinatorial chemistry 
and high throughput screening techniques 
(Samuelsson, 2004; Harvey, 2008). 
However, it is a fact that purified plant-derived 
compounds play a special role in human health care 
and botanicals are also part of pharmaceutical 
formulations such as nutraceuticals, dietary 
supplements and herbal medicinal products. In this 
sense, we believe that plants are still a useful source of 
bioactive constituents with medicinal properties 
(Newman et al., 2003; Tulp et al., 2006; Newman & 
Cragg, 2007; Newman, 2008). 
Furthermore, it has been estimated that almost 
50% of drugs in western-developed countries are 
based on natural products (most of them coming from 
plants of cultural importance) and most of the 
population in developing countries still use plants as 
primary remedies. Taking these facts into 
consideration, we are called to increase our research 
interests in traditional plants. 
Combining high throughput technology with 
selection of plants based on ethnobotanical 
information is likely to succeed in finding new 
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biological activities and compounds. We should 
consider ethnobotany a pharmaceutical research tool 
for present and future with important perspectives in 
drug discovery. 
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